Re:Compass Pathways' Phase IIb psilocybin trial shows reduce...
by rednerrus on Wednesday November 10, 2021 @11:11AM
(#29176313)
The money is in the professional therapists who administer this. It's the same model that's currently working for Ketamine.
[ Parent
| on HN ]
There are no comments on this comment yet.